Cargando…
Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer’s Disease: The Role of Naturalistic Driving Studies
Research on how preclinical and early symptomatic Alzheimer’s disease (AD) impacts driving behavior is in its infancy, with several important research areas yet to be explored. This paper identifies research gaps and suggests priorities for driving studies over the next few years among those at the...
Autor principal: | Roe, Catherine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484130/ https://www.ncbi.nlm.nih.gov/pubmed/36186730 http://dx.doi.org/10.3233/ADR-220024 |
Ejemplares similares
-
Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer’s Disease
por: Davis, Jennifer D., et al.
Publicado: (2020) -
NATURALISTIC DRIVING BEHAVIOR AS A NEUROBEHAVIORAL MARKER OF PRECLINICAL ALZHEIMER’S DISEASE
por: Babulal, Ganesh
Publicado: (2019) -
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
por: Bayat, Sayeh, et al.
Publicado: (2022) -
Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016) -
GPS driving: a digital biomarker for preclinical Alzheimer disease
por: Bayat, Sayeh, et al.
Publicado: (2021)